Tonix Pharmaceuticals HLDG C
13F holders, Q1 2025 (March 31)1holders −39
1new positions
39sold out
$0.15avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Tonix Pharmaceuticals HLDG C in their 13F filings, down 39 from Q4 2024. 1 opened new positions and 39 sold out. The largest holder was IFP Advisors, Inc ($2K).
- Company
- Tonix Pharmaceuticals HLDG C
- CUSIP
- 890260847
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2K |
| Exits | 39 | $4.8M |
All 13F filers, Q4 2024 → Q1 2025: 10,000 shares bought and 14,690,096 shares sold, net −14,680,096 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| IFP Advisors, Inc | 0.00% | New | 10,000 | $2K |
"% of holder's portfolio" is TONIX PHARMACEUTICALS HLDG C's weight in each manager's 13F, not the share of Tonix Pharmaceuticals HLDG C the manager owns.